Dr Abdul Mannan: Patient Has CAPS with 7000 Platelets – Do You Anticoagulate?
Dr Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:
“Platelets 7,000. Your patient has CAPS (Catastrophic Antiphospholipid Syndrome). Do you anticoagulate?
This is the dilemma every haematologist dreads.
Catastrophic APS (CAPS) throws you into a perfect storm: sky-high thrombotic risk meets dangerous bleeding territory. The instinct is to anticoagulate aggressively. But at 7,000 platelets, that can be fatal.
Here’s the “Bridge to Anticoagulation” approach:
Step 1: HOLD and TRANSFUSE
Stop therapeutic anticoagulation
Give platelet transfusions (unlike TTP, this is safe in CAPS)
Continue immunosuppression and plasma exchange
Step 2: Watch the Safety Window
Platelets <20k: Hold anticoagulation, continue triple therapy
Platelets 20-50k: Consider prophylactic dosing
Platelets >50k: Resume therapeutic anticoagulation
Step 3: Choose UFH
Short half-life, reversible with protamine
Avoid LMWH and warfarin initially
Rule out HIT if platelet recovery stalls
Fourth line: Eculizumab If platelets stay below 20k despite triple therapy, think complement-mediated microangiopathy. Eculizumab can be a lifesaver here.
The bottom line? Don’t let fear of thrombosis push you into fatal bleeding at 7,000. Build the platelet bridge first.
CAPS Task Force recommendations (2020) and real-world experience support this stepwise approach.
Have you managed CAPS with severe thrombocytopenia? What was your strategy?”

More posts from Dr Abdul Mannan on Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?